Arbutus Biopharma Corporation Common Stock Forecasts for Tomorrow, Week, Month and 5 Years

Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), Arbutus Biopharma Corporation Common Stock is projected near $4.49 versus the current reference around $4.43. That implies a modeled move of +1.33% over the next day, with realized prices still sensitive to intraday volatility.

The weekly Arbutus Biopharma Corporation Common Stock model points to $4.61, which maps to an expected drift of +4.12% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.

The Arbutus Biopharma Corporation Common Stock 1-month target is $4.82 (+8.79%), while the 1-year target is $5.13 (+15.77%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.

The Arbutus Biopharma Corporation Common Stock long-horizon scenario sits near $5.85 with a modeled change of +32.14%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.

For Arbutus Biopharma Corporation Common Stock, nearest resistance is around $4.30, while nearest support is around $4.56. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.

The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.